Skip to main content
Erschienen in: Medical Oncology 6/2019

01.06.2019 | Original Paper

Postmastectomy radiation therapy using VMAT technique for breast cancer patients with expander reconstruction

verfasst von: Fiorenza De Rose, Antonella Fogliata, Davide Franceschini, Salvatore Cozzi, Cristina Iftode, Antonella Stravato, Stefano Tomatis, Giovanna Masci, Rosalba Torrisi, Alberto Testori, Corrado Tinterri, Andrea V. E. Lisa, Luca Maione, Valeriano Vinci, Marco Klinger, Armando Santoro, Marta Scorsetti

Erschienen in: Medical Oncology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Postmastectomy radiotherapy (PMRT) following immediate breast reconstruction is increasingly adopted in the management of breast cancer patients. We retrospectively evaluate the complication rates of PMRT using VMAT technique to immediate tissue expander-based reconstructions and the possible impact of tissue expander volume on radiotherapy planning. We reviewed the data of patients who underwent immediate expander breast reconstruction and received PMRT with VMAT (50 Gy in 25 fractions) on the reconstructed breast and axillary levels III–IV. Neoadjuvant or adjuvant systemic therapy was administered in most of the patients. Autologous fat grafting was routinely performed at the time of second-stage reconstruction. Between 2015 and 2017, PMRT was delivered to 46 consecutive patients (median age 50 years) with expander reconstruction. Median follow-up was 27 months (range 10–41). Two patients (4.3%) had a reconstruction failure, as expander rupture and infection, following the first- and the second-stage reconstruction, respectively. In most cases expanders were completely inflated before PMRT (65.2%). Median expander volume before PMRT was 425 cm3 (range 150–700 cm3). The amount of expander inflation did not significantly affect dosimetry, except for skin dose, with a surface receiving more than 30 Gy of 36.6 ± 0.9 cm2 and 47.0 ± 2.5 cm2 for a volume expander below or above the median, respectively. However, this variable was not predictor for complications. Disease progression was recorded in 15.2% of patients. PMRT using VMAT technique for breast cancer patients with expander reconstruction is associated with a very low complication rate. The expander volume before PMRT does not significantly compromise radiotherapy dose distribution.
Literatur
1.
Zurück zum Zitat EABCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127–35. https://doi.org/10.1016/S0140-6736(14)60488-8.CrossRef EABCTCG (Early Breast Cancer Trialists’ Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, et al. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383(9935):2127–35. https://​doi.​org/​10.​1016/​S0140-6736(14)60488-8.CrossRef
2.
Zurück zum Zitat Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97(2):116–26. https://doi.org/10.1093/jnci/djh297.CrossRefPubMed Ragaz J, Olivotto IA, Spinelli JJ, Phillips N, Jackson SM, Wilson KS, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97(2):116–26. https://​doi.​org/​10.​1093/​jnci/​djh297.CrossRefPubMed
8.
Zurück zum Zitat Schechter NR, Strom EA, Perkins GH, Arzu I, McNeese MD, Langstein HN, et al. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol. 2005;28(5):485–94.CrossRef Schechter NR, Strom EA, Perkins GH, Arzu I, McNeese MD, Langstein HN, et al. Immediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol. 2005;28(5):485–94.CrossRef
13.
Zurück zum Zitat Ribuffo D, Atzeni M, Guerra M, Bucher S, Politi C, Deidda M, et al. Treatment of irradiated expanders: protective lipofilling allows immediate prosthetic breast reconstruction in the setting of postoperative radiotherapy. Aesthet Plast Surg. 2013;37(6):1146–52. https://doi.org/10.1007/s00266-013-0221-2.CrossRef Ribuffo D, Atzeni M, Guerra M, Bucher S, Politi C, Deidda M, et al. Treatment of irradiated expanders: protective lipofilling allows immediate prosthetic breast reconstruction in the setting of postoperative radiotherapy. Aesthet Plast Surg. 2013;37(6):1146–52. https://​doi.​org/​10.​1007/​s00266-013-0221-2.CrossRef
15.
Zurück zum Zitat Ibatici A, Caviggioli F, Valeriano V, Quirici N, Sessarego N, Lisa A, et al. Comparison of cell number, viability, phenotypic profile, clonogenic, and proliferative potential of adipose-derived stem cell populations between centrifuged and noncentrifuged fat. Aesthet Plast Surg. 2014;38(5):985–93. https://doi.org/10.1007/s00266-014-0372-9.CrossRef Ibatici A, Caviggioli F, Valeriano V, Quirici N, Sessarego N, Lisa A, et al. Comparison of cell number, viability, phenotypic profile, clonogenic, and proliferative potential of adipose-derived stem cell populations between centrifuged and noncentrifuged fat. Aesthet Plast Surg. 2014;38(5):985–93. https://​doi.​org/​10.​1007/​s00266-014-0372-9.CrossRef
24.
Metadaten
Titel
Postmastectomy radiation therapy using VMAT technique for breast cancer patients with expander reconstruction
verfasst von
Fiorenza De Rose
Antonella Fogliata
Davide Franceschini
Salvatore Cozzi
Cristina Iftode
Antonella Stravato
Stefano Tomatis
Giovanna Masci
Rosalba Torrisi
Alberto Testori
Corrado Tinterri
Andrea V. E. Lisa
Luca Maione
Valeriano Vinci
Marco Klinger
Armando Santoro
Marta Scorsetti
Publikationsdatum
01.06.2019
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 6/2019
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-019-1275-z

Weitere Artikel der Ausgabe 6/2019

Medical Oncology 6/2019 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.